fbpx
All about COVID19 - An initiative from WhiteCoats that brings together updates from top curated resources exclusively for healthcare professionals

The course of severe COVID-19 may be determined by the body’s antiviral response to initial infection, according to a study which opens up new avenues for early drug interventions that could prevent severe disease. Researchers from Massachusetts Institute of Technology (MIT) and Harvard University in the US analysed whether the path towards severe disease could start much earlier than expected ...

A longer gap between first and second doses of the Pfizer-BioNTech COVID-19 vaccine generates strong antibody and T cell immune responses, UK researchers have found. The study, led by the University of Oxford, in collaboration with the Universities of Birmingham, Newcastle, Liverpool, Sheffield, and supported by the UK Coronavirus Immunology Consortium, is one of the most comprehensive studies into the ...

COVID-19 vaccination has minimized many risks and complications associated with the infection. Even with breakthrough cases, and some chances of contracting COVID-19 possible, it is now known that most vaccinated people, who do get COVID-19 have a considerably lower viral load, milder symptoms, decreased risk of severe complications, and most of all, could also recover quicker. But could someone who ...

A new ICMR study has found that most Covid positive patients, who had received at least one vaccine dose before catching the infection, were infected by the Delta variant. The ICMR study is the first such analysis on breakthrough infections post-vaccination. The study shows that most vaccinated individuals were infected by the Delta variant in India. However, the death rate ...

The World Health Organization's (WHO's) chief scientist Dr Soumya Swaminathan on Monday warned against mixing and matching of Covid-19 vaccines by different manufacturers for the first and second doses, calling it a “dangerous trend” and saying that there was a lack of data about the impact of the process. “There are people who are thinking about mixing and matching. We ...

The sudden surge of COVID-19 cases in the past and the emergence of new variants time and again indicate the unpredictability of the SARs-COV-2 virus. The B.1.617.2 variant of coronavirus, also known as the Delta variant has been categorized as a Variant of Concern (VoC) and is said to have driven India's second wave. While the country returns back to ...

The World Health Organisation designated Lambda variant as a 'variant of interest' last month. It is believed to be widely prevalent in Peru and has spread to 27 nations. After Delta, the Lambda Covid-19 variant has set the alarm bells ringing across Latin America and within the World Health Organisation (WHO). Lambda has particularly puzzled scientists because of its "unusual" ...

An anti-diabetic drug ‘Ertugliflozin’ might provide a therapeutic solution to the COVID-19 infection as a repurposed drug. This is following ‘in-vitro’ and ‘in-silico’ studies done by the ASPIRE-BioNEST, a life sciences incubator jointly funded by Department of Biotechnology and University of Hyderabad (UoH), ReaGene Innovations and INDRAS Private Limited. The findings announced here on Thursday indicate that this repurposed drug ...

Two new studies have found a link between having strong response to the vaccine. One study suggests those recovered from COVID may get 10 times the antibodies to fight off infection once they are vaccinated. Dr. Andrew Jameson, an infectious disease expert with Mercy Health Saint Mercy says they may also have more side effects, "People that have had been ...

Here’s what’s happening: The immune system has two main arms, and the first kicks in as soon as the body detects a foreign intruder. White blood cells swarm to the site, prompting inflammation that’s responsible for chills, soreness, fatigue and other side effects. This rapid-response step of your immune system tends to wane with age, one reason younger people report ...